Universitaetsklinikum Tuebingen AöR

27 trials 19 recruiting Academic / non-commercial

Filter these 27 trials by condition, phase, country and more.

Open in Search →

27 Registered trials

19 Recruiting

8 Completed trials

9 Countries active

27 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase I

Phase I (FiH)

Phase III: 4 Phase II: 10 Phase I/II: 3 Phase IV: 1 Phase I: 5 Phase I (Other): 1 Phase I (FiH): 3

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

8 of 8 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Retinopathy of prematurity 2 Myelodysplastic syndrome 1 Prostate cancer recurrent 1 Alveolar rhabdomyosarcoma 1 Encephalopathy neonatal 1 Malignant melanoma 1 Parkinson's disease 1 Death neonatal 1 Neonatal asphyxia 1 Synovial sarcoma 1 Chronic kidney disease 1 Glioblastoma 1

Top IMPs

ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 8 CONTAINING THE HUMAN CNGA3 GENE UNDER THE CONTROL OF A CONE ARRESTIN PROMOTER 1 ALLOPURINOL SODIUM 1 AMANTADINE HEMISULFATE 1 BEVACIZUMAB 1 CALCIUM FOLINATE PENTAHYDRATE 1 DAPAGLIFLOZIN 1 DNAJB1-PRKACA TRIFLUORACETATE 1 ENTACAPONE, LEVODOPA, CARBIDOPA MONOHYDRATE 1 FLUDARABINE PHOSPHATE PH. EUR. 1 FLUOROURACIL 1 KETAMINE HYDROCHLORIDE 1 MB-CART2219.1 1

All trials — page 2

27 total

A phase II trial of belimumab in combination with rituximab/venetoclax in patients with refractory or relapsed chronic lymphocytic leukemia Ended

2024-511474-68-00 Phase II 1 country
Organ preservation in locally advanced rectal cancer by radiochemotherapy followed by consolidation chemotherapy. A prospective phase II pil… Ended

2024-517928-19-00 Phase II 1 country CALCIUM FOLINATE PENTAHYDRATE; FLUOROURACIL; OXALIPLATIN
Effect of ALlopurinol in addition to hypothermia for hypoxicischemic Brain Injury on Neurocognitive Outcome Ended

2024-511322-31-00 Phase III 9 countries ALLOPURINOL SODIUM

Showing 25–27 of 27 trials

← All sponsors A–Z